Evaluation of Bioequivalence for Highly Variable Drugs with Scaled Average Bioequivalence

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.48, Iss.11, 2009-11, pp. : 725-743

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Scaled Average Bioequivalence Limits Based on GMR and Variability Considerations

By Karalis Vangelis Symillides Mira Macheras Panos

Pharmaceutical Research, Vol. 21, Iss. 10, 2004-10 ,pp. : 1933-1942

Springer Publishing Company

Access to resources Recommend Favorite

Average Bioequivalence Evaluation: General Methods for Pilot Trials

By Pan Guohua

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 2, 2006-03 ,pp. : 207-225

Taylor & Francis Ltd

Access to resources Recommend Favorite

Bioequivalence of Highly Variable Drugs: A Comparison of the Newly Proposed Regulatory Approaches by FDA and EMA

By Karalis Vangelis Symillides Mira Macheras Panos

Pharmaceutical Research, Vol. 29, Iss. 4, 2012-04 ,pp. : 1066-1077

Springer Publishing Company

Access to resources Recommend Favorite

Novel Scaled Bioequivalence Limits with Leveling-off Properties

By Kytariolos John Karalis Vangelis Macheras Panos Symillides Mira

Pharmaceutical Research, Vol. 23, Iss. 11, 2006-11 ,pp. : 2657-2664

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of Average Bioequivalence of Two Oral Formulations of Amiodarone Hydrochloride after Single Administration to Healthy Volunteers

By Atanasova I.

Clinical Drug Investigation, Vol. 21, Iss. 6, 2001-06 ,pp. : 423-428

Adis International

Access to resources Recommend Favorite